mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-10 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-07 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
7e-07 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-06 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-06 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |